Advertisement

Natural Killer Cells and Diabetes Mellitus

  • Bruce A. Woda

Abstract

Diabetes mellitus has been recognized since antiquity by the classic syndrome consisting of polyuria, polydipsia, polyphagia, and glycosuria. Diabetes is a group of disorders that are associated with hyperglycemia. It is a common, serious disease of the young with a prevalence rate of 0.3% in individuals under 20 and 0.5% for individuals under 60 years of age.(1,2) Diabetes causes appreciable morbidity secondary to the complications that affect many organ systems.

Keywords

Natural Killer Natural Killer Cell Beta Cell Islet Cell Islet Cell Antibody 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    LaPorte, R., and Cruickshanks, K., 1985, Incidence and risk factors for insulin dependent diabetes, in: Diabetes in America, U.S. Dept. Health and Human Services, NIH publication 85–1468, pp. 1–12.Google Scholar
  2. 2.
    Melton, J., Palumbo, P., and Chu, C., 1983, Incidence of diabetes by clinical type, Diabetes Care 6:79–82.Google Scholar
  3. 3.
    Gepts, W., 1965, Pathologic anatomy of the pancreas in juvenile diabetes mellitis, Diabetes 14:: 1619–633.Google Scholar
  4. 4.
    Foulis, A. K., Liddle, C. N., Farquharson, M. A., Richmond, J. A., and Weir, R. S., 1986, The histopathology of the pancreas in type I (insulin dependent) diabetes mellitus: A 25–year review of deaths in patients under 20 years of age in the United Kingdom, Diabetologia 29:267–274.PubMedCrossRefGoogle Scholar
  5. 5.
    Rossini, A. A., Mordes, J. P., and Like, A. A., 1985, Immunology of insulin-dependent diabetes mellitus, Annu. Rev. Immunol. 3:289–320.PubMedCrossRefGoogle Scholar
  6. 6.
    Dorman, J., LaPorte, R., Kuller, L., Cruickshanks, K. J., Orchard, T. J., Wagener, D, K., Becker, D. J., Cavender, D. E., and Drash, A. L., 1984, The Pittsburgh insulin dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results, Diabetes 33:271–276.Google Scholar
  7. 7.
    Rimoin, D. L., and Rotter, J. I., 1985, The genetics of diabetes mellitus, in: Immunology in Diabetes( D. Andreani, U. DiMario, K. F. Federlin, and L. G. Heding, eds.), Krimpton Medical Press, Edinburgh, pp. 45–57.Google Scholar
  8. 8.
    Bottazo, G. F., Dean, B. M., NcNally, J. M., McKay, E. H., Swift, P. G. F., and Gamble, D. R., 1985, In situcharacterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis, N. Engl J. Med. 313:356–360.Google Scholar
  9. 9.
    Cudworth, A. G., and Woodrow, J. C., 1975, Evidence of HL-A linked genes in “juvenile” diabetes mellitus, Br. Med. J. 3:133–135.PubMedCrossRefGoogle Scholar
  10. 10.
    Gorsuch, A. N., Spencer, K. M., Lister, J., Wolf, E., Bottazo, G. F., and Cudworth, A. G., 1982, Can future type I diabetes be predicted? A study in families of affected children, Diabetes 31:: 862–866.Google Scholar
  11. 11.
    Platz, P., Jakobsen, B. K., Morling, N., Ryder, L. P., Svejgaard, A., Thomsen, M., Christy, M., Kromann, H., Benn, J., Nerup, J., Green, A., and Hause, M., 1981, HLA-D and Dr antigens in genetic analysis of insulin-dependent diabetes mellitus, Diabetologia 21:108–115.PubMedCrossRefGoogle Scholar
  12. 12.
    Rotter, J. I., Anderson, C. E., Rubin, R., Congleton, J. E., Terasaki, P. I., and Rimoin, D. L., 1983, An HLA genotype study of IDDM: The excess of DR3/DR4 heterozygotes allow rejection of the recessive hypothesis, Diabetes 32:169.PubMedCrossRefGoogle Scholar
  13. 13.
    Owerbach, D., Lernmark, A., Platz, P., Ryder, L. P., Rask, L., Peterson, P. A., and Ludvigsson, J., 1983, HLA-D region β-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin dependent diabetic individuals, Nature 303:815.PubMedCrossRefGoogle Scholar
  14. 14.
    Gupta, S., Fikrig, S. M., Khanna, S., and Orti, E., 1982, Deficiency of suppressor T-cells in insulin-dependent diabetes mellitus: An analysis with monoclonal antibodies, Immunol. Lett. 4:289–294.PubMedCrossRefGoogle Scholar
  15. 15.
    Buschard, K., Ropke, C., Madsbad, S., Mehlsen, J., Sorenson, T. B., and Rygaard, J., 1983, Alterations of peripheral T-lymphocyte subpopulation in patients with insulin-dependent (type I) diabetes mellitus, J. Clin. Lab. Immunol. 10:127–131.PubMedGoogle Scholar
  16. 16.
    Pozzili, P., Zuccarini, O., Iavicoli, M., Adreani, D., Sensi, M., Spencer, K. M., Bottazo, G. F., Beverly, P. C. L., Kyner, J. L., and Cudworth, A. G., 1983, Monoclonal antibody defined abnormalities of T-lymphocytes in type I (insulin dependent) diabetes, Diabetes 32:91–94.CrossRefGoogle Scholar
  17. 17.
    Selam, J. L., Clot, J., Andary, M., and Mirouze, J., 1979, Circulating lymphocyte sub-populations in juvenile insulin-dependent diabetes, Diabetologia 16:35–40.PubMedCrossRefGoogle Scholar
  18. 18.
    Hitchcock, C. L., Riley, W. J., Alamo, A., Pyka, R., and Maclaren, N. K., 1986, Lymphocyte subsets and activation in prediabetes, Diabetes 35:1416–1422.PubMedCrossRefGoogle Scholar
  19. 19.
    Jackson, R. A., Morris, M. A., Haynes, B. F., and Eisenbarth, G. S., 1982, Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus, N. Engl. J. Med. 306:785–788.PubMedCrossRefGoogle Scholar
  20. 20.
    Alviggi, L., Hoskins, P. J., Pyke, D. A., Johnston, C., Tee, D. E. H., Leslies, R. D. G., and Versani, D., 1984, Pathogenesis of insulin-dependent diabetes: A role for activated T-lymphocytes, Lancet 2:4–5.PubMedCrossRefGoogle Scholar
  21. 21.
    MacCuish, A. C., Barnes, E. W., Irvine, W. J., and Duncan, L. J. P., 1974, Antibodies to pancreatic islet cells in insulin-dependent diabetes with coexistent autoimmune disease, Lancet 2:1529–1531.PubMedCrossRefGoogle Scholar
  22. 22.
    Srikanta, S., Rabizadeh, A., Omar, M. A. K., and Eisenbarth, G. S., 1985, Assay for islet cell antibodies: Protein A—monoclonal antibody method, Diabetes 34:300–305.PubMedCrossRefGoogle Scholar
  23. 23.
    Lernmark, A., Freedman, Z. R., Hofmann, C., Rubenstein, A. H., Steiner, D. F., Jackson, R. L., Winter, R. J., and Traisman, H. S., 1978, Islet-cell-surface antibodies in juvenile diabetes mellitus, N. Engl. J. Med. 299:375–380.PubMedCrossRefGoogle Scholar
  24. 24.
    Dobersen, M. J., Scharff, J., E., Ginsberg–Fellner, F., and Notkins, A. L., 1980, Cytotoxic autoantibodies to beta cells in the serum of patients with insulin dependent diabetes mellitus, N. Engl J. Med. 303:1493–1498.Google Scholar
  25. 25.
    Eisenbarth, G. S., Morris, M. A., and Scearce, R. M., 1981, Cytotoxic antibodies to cloned rat islet cells in serum of patients with diabetes mellitus, J. Clin. Invest. 67:403–408.PubMedCrossRefGoogle Scholar
  26. 26.
    Palmer, J. P., Asplin, C. M., Clemons, P., Lyon, K., Talpati, O., Raghu, R., and Paquette, T. L., 1983, Insulin antibodies in insulin-dependent diabetics before insulin treatment, Science 222:1337–1339.PubMedCrossRefGoogle Scholar
  27. 26.
    McEvoy, R. C., Witt, M. E., Ginsberg-Fellner, F., and Rubinstein, P., 1986, Anti-insulin antibodies in children with type I diabetes mellitus. Genetic regulation of production and presence at diagnosis before insulin replacement, Diabetes 35:634–641.PubMedCrossRefGoogle Scholar
  28. 28.
    Dean, B. M., Becker, F., McNally, J., M., Tarn, A. C., Schwartz, G., Gale, E. A. M., and Bottazo, G. F., 1986, Insulin autoantibodies in the pre-diabetic period: Correlation with islet cell antibodies and development of diabetes, Diabetologia 29:339–342.Google Scholar
  29. 29.
    Del Prete, G. F., Betterte, C., Padovan, D., Erie, G., Toffolo, A., and Bersahi, G., 1977, Incidence and significance of islet-cell antibodies in different types of diabetes mellitus, Diabetes 26:909–915.PubMedGoogle Scholar
  30. 30.
    Gorsuch, A. N., Spencer, K. M., Lister, J., McHall, J. M., Bottazo, G. F., and Cudworth, A. G., 1981, Evidence for a long prediabetic period in type I (insulin dependent) diabetes mellitus, Lancet 2:1363–1365.PubMedCrossRefGoogle Scholar
  31. 31.
    Srikanta, S., Ganda, O. P., Eisenbarth, G. S., and Soeldner, J. S., 1983, Islet-cell antibodies and beta-cell function in monozygotic twins initially discordant for type I diabetes mellitus, N. Engl J. Med. 308:322–325.PubMedCrossRefGoogle Scholar
  32. 32.
    Srikanta, S., Ganda, O. P., Rabizadeh, A., Soeldner, S. S., and Eisenbarth, G., S., 1985, First-degree relatives of patients with type I diabetes mellitus. Islet cell antibodies and abnormal insulin secretion, N. Engl. J. Med. 313:461–464.PubMedCrossRefGoogle Scholar
  33. 33.
    MacCuish, A. C., Jordan, J., Campbell, C. J., Duncan, L.J. P., and Irvine, W. J., 1974, Cell-mediated immunity to human pancreas in diabetes mellitus, Diabetes 23:693–697.PubMedGoogle Scholar
  34. 34.
    Nerup, J., Anderson, O. O., Bendixen, G., Egeberg, J., and Poulsen, J. E., 1971, Antipancreatic cellular hypersensitivity in diabetes mellitus, Diabetes 20:424–427.PubMedGoogle Scholar
  35. 35.
    Boitard, C., Debray-Sachs, M., Pouplard, A., Assan, R., and Hamburger, J., 1981, Lymphocytes from diabetics suppress insulin release in vitro, Diabetologia 21:41–46.PubMedGoogle Scholar
  36. 36.
    Boitard, C., Chatenoud, L. M., and Debray-Sachs, M., 1982, In vitroinhibition of pancreatic B cell function by lymphocytes from diabetics with associated autoimmune diseases: A T cell phenomoenon, J. Immonol. 129:2529–2531.Google Scholar
  37. 37.
    Boitard, C., Saï, P., Debray-Sachs, M., Assan, R., and Hamburger, J., 1983, Anti-pancreatic immunity. In vitrostudies of cellular and humoral immune reactions directed toward pancreatic islets, Clin. Exp. Immunol. 55:571–580.Google Scholar
  38. 38.
    Charles, M. A., Suzuki, M., Waldeck, N., Dodson, L. E., Slater, L., Ong, K., Kerschnar, A., Buckingham, B., and Golden, M., 1983, Immune islet killing mechanisms associated with insulin–dependent diabetes: In vitro expression of cellular and antibody–mediated islet cell cytotoxicity in humans, J. Immunol 130:1189–1194.PubMedGoogle Scholar
  39. 39.
    Lohmann, D., Krug, J., Lampeter, E. F., Bierwolf, B., and Verlohren, H. J., 1986, Cell-mediated immune reactions against B cells and defect of suppressor cell activity in type I (insulin-dependent) diabetes mellitus, Diabetologia 29:421–425.PubMedCrossRefGoogle Scholar
  40. 40.
    Chandy, K. G., Charles, M. A., Buckingham, B., Waldeck, N., Kershnar, A., and Gupta, S., 1984, Deficiency of monoclonal antibody (Leu 7) defined NK cells in newly diagnosed insulin-dependent diabetes mellitus, Immunol Lett. 8:89–91.PubMedCrossRefGoogle Scholar
  41. 41.
    Negishi, K., Waldeck, N., Chandy, G., Buckingham, B., Kershnar, A., Fisher, L., Gupta, S., and Charles, M. A., 1986, Natural killer cell and islet killer cell activities in type I (insulin-dependent) diabetes, Diabetologia 29:352–357.PubMedCrossRefGoogle Scholar
  42. 42.
    Pozzilli, P., Sensi, M., Gorsuch, A., Bottazzo, G. F., and Cudworth, A. G., 1979, Evidence for raised K-cell levels in type-I diabetes, Lancet 1:173–175.CrossRefGoogle Scholar
  43. 43.
    Sensi, M., Pozzilli,P., Gorsuch, A. N., Bottazzo, G. F., and Cudworth, A. G., 1981, Increased killer cell activity in insulin dependent (type I) diabetes mellitus, Diabetologia 20:106–109.PubMedCrossRefGoogle Scholar
  44. 44.
    Lanier, L. L., Le, A. M., Phillips, J. H., Warner, N. L., and Babcock, G. F., 1983, Subpopulations of human natural killer cells defined by the expression of the Leu 7 (HNK-1) and Leu 11 (NK-15) antigens, J. Immunol. 131:1789–1796.PubMedGoogle Scholar
  45. 45.
    Lanier, L. L., and Loken, M. R., 1984, Human lymphocyte subpopulations identified by using HNK-1 three color immunoflourescence and flow cytometry analysis: Correlation of Leu 2, Leu 3, Leu 7, Leu 8, and Leu 11 cell surface antigen expression, J. Immunol 132:151–156.PubMedGoogle Scholar
  46. 46.
    Huang, S. W., and Maclaren, N. K., 1976, Insulin-dependent diabetes: A disease of autoaggression, Science 192:64–66.PubMedCrossRefGoogle Scholar
  47. 47.
    Sensi, M., Pozzilli, P., and Cudworth, A. G., 1981, Antibody-dependent and natural killer cytotoxicity in type I diabetes, Acta Diabet. Lat. 18:339–345.CrossRefGoogle Scholar
  48. 48.
    Kruschel, B., Jahr, H., Marx, S., and Michaelis, D., 1984, Cellular immune reactions against rat pancreatic islets mediated by antibodies from type I diabetic patients, Biomed. Biochem. Acta 5:635–639.Google Scholar
  49. 49.
    Maruyama, T., Takei, I., Matsuba, I., Tsuruoka, A., Taniyama, M., Ikeda, Y., Kataoka, K., Abe, M., and Matsuki, S., 1984, Cell-mediated cytotoxic islet cell surface antibodies to human pancreatic beta cells, Diabetologia 26:30–33.PubMedCrossRefGoogle Scholar
  50. 50.
    Like, A. A., and Rossini, A. A., 1976, Streptozotocin-induced pancreatic insulitis: New model of diabetes mellitus, Science 193:415–417.PubMedCrossRefGoogle Scholar
  51. 51.
    Craighead, J. E., and McLane, M. F., 1968, Diabetes mellitus: Induction in mice by encephalomyocarditis virus, Science 162:913–914.PubMedCrossRefGoogle Scholar
  52. 52.
    Makino, S., Kunimoto, K., Muraoka, Y., Mizushima, Y., Katagiri, K., and Tochino, Y., 1980, Breeding of a non–obese, diabetic strain of mice, Exp. Anim. 29:1–13.Google Scholar
  53. 53.
    Kanazawa, Y., Komeda, K., Sato, S., Mori, S., Akanuma, K., and Takaku, F., 1984, Non-obese-diabetic mice: Immune mechanisms of pancreatic β-cell destruction, Diabetologia 27:113–115.PubMedCrossRefGoogle Scholar
  54. 54.
    Maruyama, T., Takei, I., Taniyama, M., Kataoka, K., and Matsuki, S., 1984, Immunological aspect of non–obese diabetic mice: Immune islet cell-killing mechanism and cell-mediated immunity, Diabetologia 27:121–123.PubMedCrossRefGoogle Scholar
  55. 55.
    Miyazaki, A., Hanafusa, T., Yamada, K., Miyagawa, J., Fujino-Kurihara, H., Nakajima, H., Nonaka, K., and Tarui, S., 1985, Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: A longitudinal study, Clin. Exp. Immunol. 60:622–630.PubMedGoogle Scholar
  56. 56.
    Wicker, L. S., Miller, B. J., Coker, L. Z., McNally, S. E., Scott S., Mullen, Y., and Appel, M. C., 1987, Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse, J. Exp. Med. 165:1639–1654.PubMedCrossRefGoogle Scholar
  57. 57.
    Prochazka, M., Leiter, E. H., Serreze, D. V., and Coleman, D. L., 1987, Three recessive loci required for insulin-dependent diabetes in non-obese diabetic (NOD) mice, Science 237:286–289.PubMedCrossRefGoogle Scholar
  58. 58.
    Hattori, M., Buse, J. B., Jackson, R. A., Glichmer, L., Dorf, M. E., Minami, M., Makino, S., Moriwaki, K., Kuzuya, H., Imura, H., Strauss, W. M., Seidman, J. G., and Eisenbarth, G. S., 1986, The NOD mouse: Recessive diabetogenic gene in the major histocompatibility complex, Science 231:733–735.PubMedCrossRefGoogle Scholar
  59. 59.
    Katoaka, S., Satoh, J., Fujiya, H., Toyota, T., Suzuki, R., Itoh, K., and Kumagai, K., 1983, Immunologic aspects of the nonobese diabetic (NOD) mouse: Abnormalities of cellular immunity, Diabetes 32:247–253.CrossRefGoogle Scholar
  60. 60.
    Leiter, E. H., Prochazka, M., Coleman, D. L., Serreze, D. V., and Shultz, L. D., 1986, Genetic factors predisposing to diabetes susceptibility in mice, in: The Immunology of Diabetes Mellitus( M. A. Jaworski, G. D. Molnar, R. V. Rajotte, and B. Singh, eds.), Elsevier, Amsterdam, pp. 29–36.Google Scholar
  61. 61.
    Koike, T., Itoh, Y., Ishii, T., Ito, I., Takabayashi, K., Maruyama, N., Tomioka, H., and Yoshida, S., 1987, Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice, Diabetes 36:539–541.PubMedCrossRefGoogle Scholar
  62. 62.
    Toyota, T., Satoh, J., Oya, K., Shintani, S., and Okano, T., 1986, Streptococcal preparation (0K-432) inhibits development of type I diabetes in NOD mice, Diabetes 35:496– 499.Google Scholar
  63. 63.
    Appel, M., personal communication.Google Scholar
  64. 64.
    Ishida, N., 1986, Immunopotentiating activities of OK-432, Excerpta Medica (monograph).Google Scholar
  65. 65.
    Chappel, C. I., and Chappel, W. R., 1983, The discovery and development of the BB rat colony: An animal model of spontaneous diabetes mellitus, Metabolism 32(Suppl. 1): 8–10.PubMedCrossRefGoogle Scholar
  66. 66.
    Butler, L., Guberski, D. L., and Like, A. A., 1983, The effect of inbreeding on the BB/ W diabetic rat, Metabolism 32(Suppl. l): 51–53.PubMedCrossRefGoogle Scholar
  67. 67.
    Butler, L., Guberski, D. L., and Like, A. A., 1983, Genetic analysis of the BBAV diabetic rat, Can. J. Genet. Cytol. 25:7–15.PubMedGoogle Scholar
  68. 68.
    Nakhooda, A. F., Like, A. A., Chappel, C. I., Murray, F. T., and Marliss, E. B., 1977, The spontaneously diabetic Wistar rat. Metabolic and morphologic studies, Diabetes 26:100–112. PubMedCrossRefGoogle Scholar
  69. 69.
    Logothetopoulos, J., Valiquett, N., Madura, E., and Cvet, D., 1984, The onset and progression of pancreatic insulitis in the overt, spontaneously diabetic, young adult BB rat studied by pancreatic biopsy, Diabetes 33:33–36.PubMedCrossRefGoogle Scholar
  70. 70.
    Seemayer, T. A., Tannenbaum, G. S., Goldman, H., and Colle, E., 1982, Dynamic time course studies of the spontaneously diabetic BB Wistar rat. III. Light microscopy and ultrastructural observations of pancreatic islets of Langerhans, Am. J. Pathol 106::237– 249.Google Scholar
  71. 71.
    Like, A. A., Forster, R. M., Woda, B. A., and Rossini, A. A., 1983, T-cell subsets in islets and lymph node of BioBreeding/Worcester(BB/W) rats, Diabetes 32 (Suppl. 1): 201A.Google Scholar
  72. 72.
    Colle, E., Guttman, R. D., Seemayer, T. A., and Michel, F., 1983, Spontaneous diabetes mellitus syndrome in the rat. IV. Immunogenetic interactions of MHC and non-MHC components of the syndrome, Metabolism 32(Suppl. 1): 56–61.Google Scholar
  73. 73.
    Jackson, R. A., Buse, J. B., Rifai, R., Pelletier, D., Milford, E. L., Carpenter, C. B., Eisenbarth, G. S., and Williams, R. M., 1984, Two genes required for diabetes in BB rats. Evidence from cyclical intercrosses and backcrosses, J. Exp. Med. 159:1629–1636.PubMedCrossRefGoogle Scholar
  74. 74.
    Colle, E., Guttman, R. D., and Fuks, A., 1986, Insulin-dependent diabetes mellitus is associated with genes that map to the right of the class 1. RT 1 A locus of the major histocompatibility complex of the rat, Diabetes 35:454–458.PubMedCrossRefGoogle Scholar
  75. 75.
    Like, A. A., Guberski, D. L., and Butler, L., 1986, Diabetic BioBreeding/Worcester (BB/Wor) rats need not be lymphopenic, J. Immunol. 136:3254–3258.PubMedGoogle Scholar
  76. 76.
    Jackson, R., Rassi, N., Crump, T., Haynes, B., and Eisenbarth, G. S., 1981, The BB diabetic rat. Profound T-cell lymphocytopenia, Diabetes 30:887–889.PubMedCrossRefGoogle Scholar
  77. 77.
    Poussier, P., Nakhooda, A. F., Falk, J. A., Lee, C., and Marliss, E. B., 1982, Lymphopenia and abnormal lymphocyte subsets in the “BB” rat: Relationship to the diabetic syndrome, Endocrinology 110:1825–1827.PubMedCrossRefGoogle Scholar
  78. 78.
    Naji, A., Silver, W. K., Kimura, H., Bellgrau, D., Markham, J. F., and Barker, F., 1983, Analytical and functional studies on the T cells of untreated and immunologically tolerant diabetes-prone BB rats, J. Immunol. 130:2168–2172.PubMedGoogle Scholar
  79. 79.
    Yale, J. F., and Marliss, E. B., 1984, Altered immunity and diabetes in the BB rat, Clin. Exp. Immunol. 57:1–11.PubMedGoogle Scholar
  80. 80.
    Woda, B. A., Like, A. A., Padden, C., and McFadden, M. L., 1986, Deficiency of T cytotoxic-suppressor cells in the BB/W rat, J. Immunol. 136:856–860.PubMedGoogle Scholar
  81. 81.
    Reynolds, C. W., Sharrow, W. O., Ortaldo, J. R., and Herberman, R. B., 1981, Natural killer activity in the rat. II. Analysis of surface antigens on LGL by flow cytometry, J. Immunol. 127:2204–2208.PubMedGoogle Scholar
  82. 82.
    Reynolds, C. W., Timonen, T., and Herberman, R. B., 1981, Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells, J. Immunol. 127:282–287.PubMedGoogle Scholar
  83. 83.
    Cantrell, D. A., Robbins, R. A., Brooks, L. G., and Baldwin, R. W., 1982, Phenotype of rat natural killer cells defined by monoclonal antibodies marking rat lymphocyte subsets, Immunology 45:97–103.PubMedGoogle Scholar
  84. 84.
    Woda, B. A., McFadden, M., Welsh, R. M., and Bain, K. M., 1984, Separation and isolation of rat natural killer (NK) cells from T cells with monoclonal antibodies, J. Immunol. 132:2183–2184.PubMedGoogle Scholar
  85. 85.
    Woda, B. A., and Biron, C. A., 1986, Natural killer celt number and function in the spontaneously diabetic BB/W rat, J. Immunol. 137:1860–1866.PubMedGoogle Scholar
  86. 86.
    Gilman, S. C., Rosenberg, J. S., and Feldman, J. D., 1982, Membrane phenotype of the rat cytotoxic T lymphocyte, J. Immunol. 129:1012–1016.PubMedGoogle Scholar
  87. 87.
    Woda, B. A., and Padden, C., 1988, Biobreeding/Worcester (BB/Wor) rats are deficient in the generation of functional cytotoxic T cells, J. Immunol. 139:1514–1517.Google Scholar
  88. 88.
    Greiner, D. L., Handler, E. S., Nakano, K., Mordes, J. P., and Rossini, A. A., 1986, Absence of the RT–6 T cell subset in diabetes prone BB/W rats, J. Immunol. 136:148–151.PubMedGoogle Scholar
  89. 89.
    Elder, M. E., and Maclaren, N. K., 1983, Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat, J. Immunol. 130:1723–1731.PubMedGoogle Scholar
  90. 90.
    Jackson,R., Kadison, P., Buse, J., Rassi, N., Jegasothy, B., and Eisenbarth, G. S., 1983, Lymphocyte abnormalities in the BB rat, Metabolism 32(Suppl. l): 83–86.PubMedCrossRefGoogle Scholar
  91. 91.
    Rossini, A. A, Mordes, J. P., Pelletier, A. M., and Like, A. A, 1983, Transfusions of whole blood prevent spontaneous diabetes mellitus in the BB/W rat, Science 219:975–977.PubMedCrossRefGoogle Scholar
  92. 92.
    Bellgrau, D., Naji, A., Silvers, W. K., Markmann, J. F., and Barker, C. F., 1982, Spontaneous diabetes in BB rats—evidence for the T-cell dependent immune response defect, Diabetologia 23:359–364.PubMedCrossRefGoogle Scholar
  93. 93.
    Prud’homme, G. J., Freks, A., Colle, E., Seemayer, T. S., and Guttmann, R. D., 1984, Immune dysfunction in diabetes-prone BB rats: Interleukin-2 production and other mitogen-induced responses are suppressed by activated macrophages, J. Exp. Med. 159:463–478.PubMedCrossRefGoogle Scholar
  94. 94.
    Woda, B. A., and Padden, C., 1986, Mitogen responsiveness of lymphocytes from the BB/W rat, Diabetes 35:513–516.PubMedCrossRefGoogle Scholar
  95. 95.
    Elder, M., Maclaren, N., Riley, W., and McConnel, T., 1982, Gastric parietal cell and other autoantibodies in the BB rat, Diabetes 31:313–318.PubMedCrossRefGoogle Scholar
  96. 96.
    Like, A. A., Appel, M. C., and Rossini, A. A., 1982, Autoantibodies in the BB/W rat, Diabetes 31:816–820.PubMedCrossRefGoogle Scholar
  97. 97.
    Pollard, D. R., Gupta, K., Mancion, L., and Hynie, I., 1983, An immunofluorescence study of anti-pancreatic islet cell antibodies in the spontaneously diabetic BB Wistar rat, Diabetologia 25:56–59.PubMedCrossRefGoogle Scholar
  98. 98.
    Martin, D. R., and Logothetopoulos, J., 1984, Complement-fixing islet cell antibodies in the spontaneously diabetic BB rat, Diabetes 33:93–97.PubMedCrossRefGoogle Scholar
  99. 99.
    Dyrberg, T., Poussier, P., Nakhooda, A. F., Baekkeskov, S., Marliss, E. B., and Lern-mark, A., 1984, Islet cell surface and lymphocyte antibodies often precede spontaneous diabetes in the BB rat, Diabetologia 26:159–165.PubMedCrossRefGoogle Scholar
  100. 100.
    Laborie, C., Sai, P., Feutren, G., Debray-Sachs, M., Quiniou-Debrie, M. C., Poussier, P., Marliss, E. B., and Assan, R., 1985, Time course of islet cell antibodies in diabetic and non-diabetic BB rats, Diabetes 34:904–910.PubMedCrossRefGoogle Scholar
  101. 101.
    MacKay, P., Jacobson, J., and Rabinovitch, A., 1986, Spontaneous diabetes mellitus in the Bio-Breeding/Worcester rat: Evidence in vitrofor natural killer cell lysis of islet cells, J. Clin. Invest. 77:916–924.PubMedCrossRefGoogle Scholar
  102. 102.
    Like, A. A., Biron, C. A., Weringer, E. J., Byman, K., Srocaynski, E., and Guberski, D. L., 1986, Prevention of diabetes in BioBreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells, J. Exp. Med. 164:1145–1159.PubMedCrossRefGoogle Scholar
  103. 103.
    Woda, B. A., Handler, E. S., Padden, C., Greiner, D. L., Reynolds, C., and Rossini, A. A., 1987, Anti-asialo GM1 (AGM1) prevents diabetes in diabetes prone (DP) but not RT 6.1 depleted diabetes resistant (DR) Biobreeding/Wor rats, Diabetes 36 (Suppl. 1): 66A.Google Scholar
  104. 104.
    Koevary, S., Rossini, A. A., Stoller, W., Chick, W., and Williams, R. M., 1983, Passive transfer of diabetes in the BB/W rat, Science 220:727–728.PubMedCrossRefGoogle Scholar
  105. 105.
    Like, A. A., Weringer, E. J., Holdash, A., McGill, P., Atkinson, D., and Rossini, A. A., 1984, Adoptive transfer of autoimmune diabetes mellitus in BioBreeding/Worcester (BB/W) inbred and hybrid rats, J. Immunol. 134:1583–1587.Google Scholar
  106. 106.
    Handler, E. S., Mordes, J. P., Seals, J., Koevary, S., Like, A. A., Nakano, K., and Rossini, A. A., 1985, Diabetes in the Bio-Breeding/Worcester (BB/W) rat: Induction and acceleration by spleen cell conditioned media, J. Clin. Invest. 76:1692–1694.PubMedCrossRefGoogle Scholar
  107. 107.
    Greiner, D. L., Mordes, J. P., Handler, E. S., Angelillo, M., Nakamura, N., and Rossini, A. A., 1987, Depletion of RT 6.1+ T lymphocytes induces diabetes in resistant Bio-Breeding/Worcester (BB/W) rat, J. Exp. Med. 166:461–475.PubMedCrossRefGoogle Scholar
  108. 108.
    Prud’homme, G. J., Fuks, A., Colle, E., and Guttman, R. D., 1984, Isolation of T-lymphocyte lines with specificity for islet cell antigens from spontaneously diabetic (insulin-dependent) rats, Diabetes 33:801–803.PubMedCrossRefGoogle Scholar
  109. 109.
    Prud’homme, G. J., Fuks, A., Guttman, R. D., and Colle, E., 1985, T cell hybrids with specificity for islet cell antigens, J. Immunol. 136:1535–1536.Google Scholar
  110. 110.
    Like, A. A., Kislauskis, E., Williams, R. M., and Rossini, A. A., 1982, Neonatal thymectomy prevents spontaneous diabetes mellitus in the BB/W rat, Science 216:644–646.PubMedCrossRefGoogle Scholar
  111. 111.
    Like, A. A., Rossini, A. A., Appel, M. C., Guberski, D. L., and Williams, R. M., 1979, Spontaneous diabetes mellitus: Reversal and prevention in the BB/W rat with antiserum to rat lymphocytes, Science 206:1421–1423.PubMedCrossRefGoogle Scholar
  112. 112.
    Rossini, A. A., Slavin, S., Woda, B. A., Geisberg, M., Like, A. A, and Mordes, J. P., 1984, Total lymphoid irradiation prevents diabetes mellitus in the Bio-Breeding/ Worcester (BB/W) rat, Diabetes 33:543–547.PubMedCrossRefGoogle Scholar
  113. 113.
    Laupacis, A., Gardell, C., Dupree, J., Stiller, C. R., Keown, P., and Wallace, A. C., 1983, Cyclosporin prevents diabetes in BB Wistar rat, Lancet 1:10–11.PubMedCrossRefGoogle Scholar
  114. 114.
    Like, A. A., Dirodi, V., Thomas, S., Guberski, D., and Rossini, A. A., 1984, Prevention of diabetes mellitus in the BB/W rat with cyclosporine-A, Am. J. Pathol. 117:92–97.PubMedGoogle Scholar
  115. 115.
    Naji, A. Silver, W. K., Bellgrau, D., and Barker, C. F., 1981, Destruction of islets is prevented by immunological tolerance, Science 213:1390–1392.PubMedCrossRefGoogle Scholar
  116. 116.
    Rossini, A. A., Faustman, D., Woda, B. A., Like, A. A., Szymanski, I., and Mordes, J. P., 1984, Lymphocyte transfusions prevent diabetes in the BioBreeding Worcester rat, J. Clin. Invest. 74:39–46.PubMedCrossRefGoogle Scholar
  117. 117.
    MacKay, P., Boulton, A., and Rabinovitch, A., 1985, Lymphoid cells of BB/W diabetic rats are cytotoxic to islet beta cells in vitro, Diabetes 34:706–709.CrossRefGoogle Scholar
  118. 118.
    Weringer, E. J., and Like, A. A., 1985, Immune attack on pancreatic islet transplants in the spontaneously diabetic Bio–breeding/Worcester (BB/W) rat is not MHC-restricted, J. Immunol. 134:2383.PubMedGoogle Scholar
  119. 119.
    Prowse, S. J., Bellgrau, D., and Lafferty, K. J., 1986, Islet allografts are destroyed by disease occurrence in the spontaneously diabetic BB rat, Diabetes 35:110–114.PubMedCrossRefGoogle Scholar
  120. 120.
    Bendtzen, K., Mandrup–Poulsen, T., Nerup, J., Nielsen, J. H., Dinarello, C. A., and Svenson, M., 1986, Cytotoxicity of human pi interleukin-1 for pancreatic islets of Langerhans, Science 232:1545–1547.PubMedCrossRefGoogle Scholar
  121. 121.
    Mandrup-Poulsen, T., Bendtzen, K., Dinarello, C. A., and Nerup, J., 1987, Interleukin-1 (IL-1)—mediated beta-cell killing: Potentiating effect of tumor necrosis factor (TNF), Diabetes 36 (Suppl. 1):40A.Google Scholar
  122. 122.
    Scala, G., Allavena, P., Djeu, J. Y., Kasahara, T., Ortaldo, J. R., Herberman, R. B., and Oppenheim, J. J., 1984, Human large granular lymphocytes are potent producers of interleukin-1, Nature 309:56–59.PubMedCrossRefGoogle Scholar
  123. 123.
    Farkus, G., Pusztai, R., Mandi, Y., and Beladi, I., 1983, In vitromodel for cellular cytotoxicity against rat Langerhans’ islets: Protective effect of mouse interferon on rat target cells, Transplantation 36:583–584.Google Scholar
  124. 124.
    Wang, Y., Hao, L., Gill, R. G., and Lafferty, K. J., 1986, Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent, Diabetes 36:535–538.CrossRefGoogle Scholar
  125. 125.
    Sedgwick, J., Brostoff, S., and Mason, D., 1987, Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction, J. Exp. Med. 165:1058–1075.PubMedCrossRefGoogle Scholar
  126. 126.
    Appel, M., personal communication.Google Scholar
  127. 127.
    Schwizer, R. W., Leiter, E. H., and Evans, R., 1984, Macrophage-mediated cytotoxicity against cultured pancreatic islet cells, Transplantation 37:539–544.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Bruce A. Woda
    • 1
  1. 1.Department of PathologyUniversity of Massachusetts Medical CenterWorcesterUSA

Personalised recommendations